Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 10, 2023
X-Chem announced the addition of Karen Lackey as chief scientific officer (CSO) and David Hagerman as chief financial officer (CFO) to its global executive management team.
read more
Thursday, August 10, 2023
Phastar announced the appointment of Graham Clark as the new Chief Executive Officer. Amid ambitious growth plans and organizational changes, Clark will succeed Andrew MacGarvey as CEO and further boost the paradigm shift in delivery of world-class ...
read more
The PPD clinical research business of Thermo Fisher Scientific was granted a five-year award to provide a Transplantation Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases (NIAID), part of the ...
read more
Bios Health Group entered into the Life Science market to help biotech entrepreneurs and executives take their innovative ideas to the next level.
read more
SSI Strategy announced that it has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy.
read more
Thursday, August 17, 2023
The National Institutes of Health (NIH), the US’s medical research agency, selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, oncolytic viruses, and nucleic acid-...
read more
Biocytogen Pharmaceuticals announced the grand opening of a new 37,000 square foot facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
read more
Biocytogen Pharmaceuticals announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth.
read more
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a De Novo approval by the FDA for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new...
read more
TraceLink, a digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, announced its continuing support of Drug Supply ...
read more
Wednesday, August 23, 2023
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization specializing in the advancement of cell and gene therapies, announces a collaboration with Rentschler Biopharma, a leading global contract ...
read more
Thursday, August 24, 2023
Charles River Laboratories International, Inc. announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon.
read more
Trialogics, a clinical trial software and services company, providing eConsent, IRT (RTSM), and eCOA, announced that it is growing its overall services by expanding its Remote Device Management capabilities.
read more
BostonGene, a provider of AI-based molecular and immune profiling solutions, NEC Corporation, a provider of IT, network and AI technologies, and Japan Industrial Partners, a Tokyo-based private equity firm, announced the formation of BostonGene Japan...
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within ...
read more